Understanding acid-glycol switchable emulsifiers on the molecular scale.

Switchable emulsifiers are commonly studied at the macroscopic scale without significant insight into the molecular properties and processes underpinning their behaviour. This work aims to investigate on the molecular scale a switchable emulsifier comprising poly(methacrylic acid) (PMAA) and poly(ethylene glycol) methacrylate (PEGMA). This emulsifier forms stable oil/water emulsions at pH > 10, but the emulsion becomes unstable at pH < 3 due to droplet aggregation.

Unravelling the interfacial water structure at the photocatalyst strontium titanate by sum frequency generation spectroscopy.

The direct conversion of solar energy to hydrogen is considered as a possible method to produce carbon neutral hydrogen fuel. The mechanism of photocatalytic water splitting involves the chemical breakdown of water and re-assembly into hydrogen and oxygen at the interface of a photocatalyst. The selection rules of a suitable material are well established, but the fundamental understanding of the mechanisms, occurring at the interface between the catalyst and the water, remains missing.

European solvent industry group generic exposure scenario risk and exposure tool.

The European Solvents Industry Group (ESIG) Generic Exposure Scenario (GES) Risk and Exposure Tool (EGRET) was developed to facilitate the safety evaluation of consumer uses of solvents, as required by the European Union Registration, Evaluation and Authorization of Chemicals (REACH) Regulation. This exposure-based risk assessment tool provides estimates of both exposure and risk characterization ratios for consumer uses. It builds upon the consumer portion of the European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC) Targeted Risk Assessment (TRA) tool by implementing refinements described in ECETOC TR107.

Serotonin transporter deficiency protects mice from mechanical allodynia and heat hyperalgesia in vincristine neuropathy.

Painful vincristine (VCR) neuropathy is a frequent and dose-limiting problem in cancer treatment. Here, we investigated how pain behavior is modulated in mice lacking the serotonin transporter (5-HTT-/- mice) after inducing neuropathy by intraperitoneal injections of VCR. We used standard tests for evoked pain, high performance liquid chromatography to measure serotonin (5-HT), and immunohistochemistry of L4/5 dorsal root ganglia (DRG) to assess neuronal injury and inflammation.